{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-094337","form_type":"8-K","ticker":"CELU","cik":"0001752828","company_name":"Celularity Inc","filed_at":"2023-04-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:40.381877+00:00","generated_at":"2026-06-17T04:39:58.120570+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Celularity raises $6M in registered direct offering at $0.65/unit; existing warrants repriced to $0.75","bullets":["Celularity sells 9,230,770 shares and warrants for ~$6M total gross proceeds at $0.65 per combined unit.","New warrants have exercise price of $0.75, exercisable 6 months after issuance, expire 5 years later.","Existing warrants on 4,054,055 shares amended: exercise price cut from $8.25 to $0.75, expiration extended.","Proceeds to be used for working capital and repayment of a pre-paid advance agreement with YA II PN, Ltd."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-094337","json":"https://secwatch.observer/filing/0001193125-23-094337.json","markdown":"https://secwatch.observer/filing/0001193125-23-094337.md","text":"https://secwatch.observer/filing/0001193125-23-094337.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1752828/000119312523094337/0001193125-23-094337-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1752828/000119312523094337/d494893d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T04:39:58.120570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4805c3c187d10ff57aa99c3565fcf210ff2a7032","claim":"Celularity Inc entered into Placement Agency Agreement with A.G.P./Alliance Global Partners (effective 2023-04-04).","evidence_excerpt":"In connection with the Purchase Agreement, Celularity entered into a placement agency agreement, or Placement Agency Agreement, with A.G.P./Alliance Global Partners, or A.G.P., pursuant to which A.G.P. agreed to serve as exclusive placement agent for the issuance and sale of the shares of Class A common stock and accompanying warrants.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000119312523094337/0001193125-23-094337-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"A.G.P./Alliance Global Partners"},{"label":"Effective","value":"2023-04-04"}],"fact_type":"material_agreement"},{"claim_id":"8b5bd3740d41bf7a273657598f2f40cfb4f5436b","claim":"Celularity Inc entered into Purchase Agreement with institutional accredited investor valued at approximately $6.0 million (effective 2023-04-04).","evidence_excerpt":"On April 4, 2023, Celularity Inc, or Celularity, entered into a securities purchase agreement with an institutional accredited investor, or the Purchase Agreement, providing for the sale and issuance of (i) 9,230,770 shares of its Class A common stock, par value $0.0001 per share, or the Class A common stock, and (ii) accompanying warrants to purchase up to 9,230,770 shares of Class A common stock, at a combined purchase price of $0.65 per share and accompanying warrant, for an aggregate purchase price of approximately $6.0 million.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1752828/000119312523094337/0001193125-23-094337-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"institutional accredited investor"},{"label":"Value","value":"approximately $6.0 million"},{"label":"Effective","value":"2023-04-04"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}